Medical Devices Singapore

Singapore Deep Brain Stimulation Market Analysis, 2024–2034

Updated Reviewed by Chandani Patel

Singapore Deep Brain Stimulation Market Industry Trends and Forecast to 2034: Segmented by (Product, Indication, End User, Region) - Growth, Market Size, Future Prospects & Competitive Analysis, 2024-2034

Overview

Market Dashboard

Singapore · 2024–2034 · placeholder estimates

Values shown here are placeholder estimates, not researched figures. Researched 2024 historical, 2025 base-year and 2026–2034 forecast values are prepared with the full report.

Estimate 2024 $1.5 Mn Placeholder estimate
Estimate 2025 $1.7 Mn 0.1% of the global market
Projected 2034 $4.0 Mn 133.9% Adds $2.3 Mn over 9 forecast years
CAGR 2025–2034 9.9% Faster than 55% of 173 Medical Devices markets here
Key players 5
  • Singapore is 0.1% of the global market.
  • In APAC, the largest is China at $122.4 Mn.
  • Fastest growing: India at 11.9% a year.
  • Singapore ranks 10th of 10 by size in APAC.

Market size projection

Singapore

Source: Acuitas Health Analytics. Full methods, sources and usage terms come with report purchase.

Value added each year

$2.3 Mn total, 2026–2034

Year-by-year market size, 2024–2034
Deep Brain Stimulation Market market size by year, Singapore
YearMarket sizeChange that yearSince 2025
2024 (estimate) $1.5 Mn — —
2025 (base) $1.7 Mn +$0.2 Mn —
2026 (forecast) $1.9 Mn +$0.2 Mn +9.9%
2027 (forecast) $2.0 Mn +$0.2 Mn +20.8%
2028 (forecast) $2.2 Mn +$0.2 Mn +32.7%
2029 (forecast) $2.5 Mn +$0.2 Mn +45.9%
2030 (forecast) $2.7 Mn +$0.2 Mn +60.3%
2031 (forecast) $3.0 Mn +$0.3 Mn +76.2%
2032 (forecast) $3.3 Mn +$0.3 Mn +93.6%
2033 (forecast) $3.6 Mn +$0.3 Mn +112.8%
2034 (forecast) $4.0 Mn +$0.4 Mn +133.9%

Placeholder estimates. Each year is projected from our earlier market estimate and its CAGR. Researched values come with the full report.

Same market worldwide

By geography

  1. Global $1.66 Bn
  2. North America $928.7 Mn
  3. US $608.6 Mn
  4. Europe $331.2 Mn
  5. APAC $317.0 Mn
  6. China $122.4 Mn
  7. Canada $116.2 Mn
  8. Japan $90.9 Mn
  9. Latin America $74.7 Mn
  10. Middle East $67.8 Mn
  11. Germany $56.4 Mn
  12. France $50.4 Mn
  13. Brazil $41.4 Mn
  14. Italy $39.7 Mn
  15. UK $38.2 Mn
  16. Ecuador $34.5 Mn
  17. Spain $33.4 Mn
  18. India $34.8 Mn
  19. Saudi Arabia $31.9 Mn
  20. Mexico $28.5 Mn
  21. Africa $24.3 Mn
  22. Australia $21.6 Mn
  23. New Zealand $15.7 Mn
  24. Russia $15.2 Mn
  25. South Africa $10.1 Mn
  26. UAE $9.7 Mn
  27. Egypt $4.2 Mn
  28. Philippines $4.0 Mn
  29. Hong Kong $2.7 Mn
  30. Malaysia $2.6 Mn
  31. Thailand $2.3 Mn
  32. Singapore (this report) $1.7 Mn
  33. Kenya $1.3 Mn

Report snapshot

Singapore Deep Brain Stimulation Market Analysis at a glance
Market size, 2025$1.7 Mn placeholder estimate
Forecast, 2034$4.0 Mn placeholder estimate
Growth (CAGR), 2025–20349.9% placeholder estimate
Years2024 historical · 2025 base year · 2026–2034 forecast
SegmentsProduct, indication and end user (see all)
Key playersMedtronic, Boston Scientific Corporation, Abbott Laboratories, Newronika, SceneRay (see all)
Regulator in SingaporeHSASource: Health Sciences Authority. Checked 14 Nov 2026.
FormatsPDF, PPTX, XLSX

Sizes and growth here are placeholder estimates, not researched figures. Researched figures come with the full report.

The Singapore Deep Brain Stimulation Market Analysis Executive Summary

Deep brain stimulation places thin wires in the brain connected to a pacemaker-like device, to treat Parkinson's, tremor and other conditions.

Key segments of the deep Brain Stimulation market include product (Single-Channel, Dual-Channel and Rechargeable) and indication (Parkinson's, Essential Tremor and Dystonia).

Bar chart: Singapore Deep Brain Stimulation market size, 2024–2034, placeholder estimates. $1.5 Mn in 2024, $1.7 Mn in 2025 and $4.0 Mn in 2034, 9.9% CAGR.
Singapore Deep Brain Stimulation market size, 2024–2034. Placeholder estimates; researched figures come with the full report. Source: Acuitas Health Analytics.

Singapore Deep Brain Stimulation Market Dynamics

Market Growth Drivers

An ageing population, more people living with brain and nerve diseases, better diagnosis and the first disease-modifying treatments are driving the deep Brain Stimulation market.

Opportunity

Biomarker-guided treatment, earlier diagnosis and new device-based therapies give the deep Brain Stimulation market strong room to grow.

Market Restraints

Hard-to-reach brain targets, high failure rates in trials, side effects and high prices for new therapies hold back the deep Brain Stimulation market.

Competitive Landscape for Deep Brain Stimulation Market in Singapore

The deep Brain Stimulation market is moderately concentrated. Leading companies compete on product innovation, clinical evidence, pricing and geographic reach, and use partnerships and acquisitions to expand their portfolios.

Key Players

Healthcare Policies and Regulatory Landscape for Deep Brain Stimulation Market in Singapore

Deep Brain Stimulation in Singapore: rules and payment

Medical devices must be registered with the Health Sciences Authority (HSA), except low-risk Class A devices.⁠[1] MediShield Life gives basic health insurance to all citizens and permanent residents, alongside MediSave savings accounts.⁠[2]

[1] Health Sciences Authority. Checked 14 Nov 2026.

[2] CPF Board, MediShield Life. Checked 14 Nov 2026.

Policy changes and Reimbursement scenario

Medical device rules, such as the US FDA 510(k) and PMA pathways and the EU Medical Device Regulation, govern how deep Brain Stimulation products are approved and monitored. Reimbursement codes and hospital purchasing policies decide how widely they are used in Singapore.

Beyond the market numbers

Research, trials and patients

What doctors and scientists are doing in Deep Brain Stimulation right now, from free public sources.

Latest research 7,259 papers since 2021 (worldwide)

  1. Refractory Meige syndrome treated with bilateral globus pallidus internus deep brain stimulation. BMJ case reports, 2026
  2. Computer vision-derived gait-state tracking of acute treatment response in Parkinson's disease: external and prospective validation. NPJ Parkinson's disease, 2026
  3. Rehabilitation Strategies for Focal Hand Dystonia:A Narrative Review with Systematic Approach. The journal of medical investigation : JMI, 2026
  4. Continuous Recording of Local Field Potentials via Deep Brain Stimulation Electrodes in Parkinson's Disease:A Technical and Conceptual Review. The journal of medical investigation : JMI, 2026
  5. Flexible recording electrodes preliminarily reveal the brain-spinal circuit mechanism of spinal cord stimulation in the treatment of motor impairment in the mouse model of Parkinson's disease. Science China. Life sciences, 2026
Search all of them on PubMed (opens in a new tab)

Sources: PubMed (US National Library of Medicine), ClinicalTrials.gov, World Bank. Fetched 12 Nov 2026. Papers and trials are found by search words, so the counts are a guide. Titles only; read each paper at its source.

Public data, with sources

Deep Brain Stimulation in context

Singapore compared

  • Health spending per person: 3,922 US$ per person (2023). World: 1,317 US$ per person (2023). 3rd highest of the 15 countries we cover in APAC.[1]
  • Doctors: 2.83 per 1,000 people (2022). World: 1.86 per 1,000 people (2022). 4th highest of the 15 countries we cover in APAC.[2]
  • People aged 65 and over: 14.2% of people (2025). World: 10.4% of people (2025). 7th highest of the 16 countries we cover in APAC.[3]

[1] World Bank Open Data, Health spending per person (US$ per person). Retrieved 14 Nov 2026.

[2] World Bank Open Data, Doctors (per 1,000 people). Retrieved 14 Nov 2026.

[3] World Bank Open Data, People aged 65 and over (% of people). Retrieved 15 Nov 2026.

Free data on this topic

Quick answers

Frequently asked questions

How big is the Deep Brain Stimulation market in Singapore?
Placeholder estimate: about $1.7 Mn in 2025, rising to about $4.0 Mn by 2034. These are early estimates, not researched figures; the researched values come with the full report.
How fast is the Deep Brain Stimulation market in Singapore growing?
Placeholder estimate: about 9.9% a year (CAGR, 2025–2034). The researched growth rate comes with the full report.
What segments does the Deep Brain Stimulation market report cover?
The report splits the market by product (Single-Channel, Dual-Channel, Rechargeable, Adaptive Systems), indication (Parkinson's, Essential Tremor, Dystonia, Epilepsy and more) and end user (Hospitals, Ambulatory Surgical Centers, Diagnostic Centers, Home Care Settings).
Who are the key players in the Deep Brain Stimulation market?
Key players include Medtronic, Boston Scientific Corporation, Abbott Laboratories, Newronika and SceneRay.
What is driving the Deep Brain Stimulation market?
An ageing population, more people living with brain and nerve diseases, better diagnosis and the first disease-modifying treatments are driving the deep Brain Stimulation market.
Who regulates Deep Brain Stimulation in Singapore?
Medical devices must be registered with the Health Sciences Authority (HSA), except low-risk Class A devices. Source: Health Sciences Authority. Checked 14 Nov 2026.
How is healthcare paid for in Singapore?
MediShield Life gives basic health insurance to all citizens and permanent residents, alongside MediSave savings accounts. Source: CPF Board, MediShield Life. Checked 14 Nov 2026.
How much research is published on Deep Brain Stimulation?
PubMed lists 7,259 papers on Deep Brain Stimulation added since January 2021, worldwide. Source: PubMed, Papers added since 1 January 2021 matching this market. Retrieved 12 Nov 2026.
Get a free sample The table of contents and sample pages. No payment needed. Request sample Consult Us Questions about Deep Brain Stimulation in Singapore? Our analysts can size it for your plan. Talk to us See the public data Health figures for every country, free. Open the Public Health Dashboard

From our blog

Brain Cancer Diagnosis: Imaging and New BiomarkersAbout 321,000 people were diagnosed with brain and nervous system tumours in 2022, and about 248,000 died… Alzheimer's Diagnosis: Blood Tests and Earlier Answers57 million people live with dementia. In May 2025 the US FDA cleared the first blood test used to help… Cannabis-Based Medicines: Science and RegulationThe FDA has approved one cannabis-derived medicine, Epidiolex, for rare epilepsies, and three synthetic…
Back to Catalogue
Keep exploring

Related Medical Devices reports in Singapore

See all
Same topic, other categories

Related on brain and nerves

See the topic